Follow

Submissions from 2011

PDF

Beyond Early Intervention, Amresh Srivastava

PDF

Pregnant Women as Research Participants: Why Is Additional Protection Required?, Kyoko Wada

Submissions from 2010

PDF

Current Understanding and Pharmacological Management of Suicide Behavior in Clinical Setting, Amresh Shrivastava

PDF

Predictors and Characteristics of Response and Nonresponse: A Ten Year Follow-Up of First Episode Schizophrenia in Mumbai, Amresh Shrivastava, Nilesh Shah, Megan Johnston, Larry Stitt, Meghana Thakar, and Gurusamy Chinnasamy

PDF

Should 'Risk Syndrome of Psychosis' Be Included in DSM V as a Diagnosis? A Road towards Preventive Psychiatry, Amresh Srivastava

PDF

Enhancing Risk Assessment across Mental Health Services, Amresh Srivastava, Megan Johnston, and Charles Nelson

PDF

Psychoendocrinology (Thyroid Hormone) and Early Psychosis: Preliminary Findings, Amresh Srivastava, Megan Johnston, Lenore Purde, and Robbie Campbell

PDF

Serum Lipids and Suicidality in Early Psychosis: Is There a Connection? A Preliminary Study, Amresh Srivastava, Megan Johnston, Lenore Purde, and Robbie Campbell

PDF

Antipsychotics and Outcome in Schizophrenia, Amresh Srivastava and Anukant Mital

PDF

Do Atypical Antipsychotics Differ in Determining Long-term Outcome of First Episode Schizophrenia? A Naturalistic Outcome Study in India, Amresh Srivastava, Nilesh Shah, Megan Johnston, Larry Stitt, Meghana Thakar, Gurusamy Chinnasamy, and Anukant Mital

PDF

Never the Twain Shall Meet? Interspecialty Bioethics Education and Practice in Relation to Informed Consent for Surgery-related Anesthesia, Kyoko Wada and Abraham Rudnick

Submissions from 2009

PDF

Clinical Interview for Psychiatric Assessment, Amresh Srivastava

PDF

Early Psychosis: A Novel Gateway for Suicide Prevention, Amresh Srivastava

PDF

Identifying Schizophrenia: Paradigm Shift ‘The UHR Research’, Amresh Srivastava

PDF

Selecting Antidepressant Drugs for Management of Depression in Primary Care (Part 1), Amresh Srivastava

PDF

Selecting Antidepressant Drugs for Management of Depression in Primary Care (Part 2), Amresh Srivastava

PDF

Should Schizoaffective Disorder Be Dropped from DSM V, Amresh Srivastava

PDF

Switching and Selecting Atypical Antipsychotic Drugs: Paliperidone, Amresh Srivastava

PDF

Switching and Selecting Atypical Antipsychotic Drugs: Quetiapine, Amresh Srivastava

PDF

Treatment Resistant Depression, Amresh Srivastava

PDF

Coping up Challenges of Risk Assessment: Towards a New Scale: SIS-MAP, Amresh Srivastava and Charles Nelson

PDF

First Episode Is the Best Episode: Lessons and Limitations in Duration of Untreated Psychosis (DUP) and Outcome in Schizophrenia, Amresh Srivastava, Larry Stitt, Meghana Thakar, Gurusamy Chinnasamy, and Nilesh Shah

PDF

Baseline Serum Prolactinin Drug Naïve First Episode Schizophrenia Predicts a Positive Clinical and Social Outcome at Five Years, Post Discharge Follow-up, Amresh Srivastava, Manoj Tamhane, Meghana Thakar, Yves Bureau, and Nilesh Shah

Submissions from 2008

PDF

Cannabis & Psychosis: The Interface Emerging Frontiers for Research, Amresh Shrivastava

Link

Brain, Mind and Behaviour - Emerging Biological Connections, Amresh Srivastava